Back to HomeBeta

ICD-10 Coding for Connective Tissue Disease(M32.1, M34.0, M35.1)

Complete ICD-10-CM coding and documentation guide for Connective Tissue Disease. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Systemic Connective Tissue DisordersMixed Connective Tissue DiseaseUndifferentiated Connective Tissue Disease

Quick Navigation

Related ICD-10 Code Ranges

Complete code families applicable to Connective Tissue Disease

M30-M36Primary Range

Systemic connective tissue disorders

This range includes all systemic connective tissue disorders, which are the primary focus for coding and documentation.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
M32.1Systemic lupus erythematosus with organ or system involvementUse when SLE is confirmed with specific organ involvement.
  • Positive anti-dsDNA
  • Renal biopsy showing lupus nephritis
M34.0Progressive systemic sclerosisUse when systemic sclerosis is confirmed with skin and organ involvement.
  • Skin thickening proximal to MCP joints
  • Esophageal dysmotility on manometry
M35.1Mixed connective tissue diseaseUse when MCTD is confirmed with specific antibody tests.
  • Positive anti-U1 RNP antibodies
  • Raynaud's phenomenon

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for connective tissue disease

Essential facts and insights about Connective Tissue Disease

The ICD-10 code range for connective tissue diseases is M30-M36, including conditions like SLE and MCTD.

Primary ICD-10-CM Codes for connective tissue disease

M32.1
Systemic lupus erythematosus with organ or system involvement
Non-billable Code

Decision Criteria

clinical Criteria

  • Positive anti-dsDNA and organ involvement

Applicable To

  • Lupus nephritis
  • Neuropsychiatric lupus

Excludes

  • Drug-induced lupus erythematosus (M32.0)

Clinical Validation Requirements

  • Positive anti-dsDNA
  • Renal biopsy showing lupus nephritis

Code-Specific Risks

  • Incorrect sequencing with manifestation codes

Coding Notes

  • Ensure organ involvement is documented with specific tests.
View Full Code Details

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Glomerular disorders in diseases classified elsewhere

N08.5
Use to specify renal involvement in SLE.

Pulmonary hypertension due to connective tissue disease

I27.23
Use to specify pulmonary involvement in systemic sclerosis.

Other specified interstitial pulmonary diseases

J84.89
Use to specify lung involvement in MCTD.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Mixed connective tissue disease

M35.1
Presence of anti-U1 RNP antibodies differentiates MCTD from SLE.

Unspecified systemic involvement of connective tissue

M35.9
Lack of specific organ involvement or antibody tests.

Systemic lupus erythematosus with organ or system involvement

M32.1
Anti-dsDNA and specific organ involvement.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Connective Tissue Disease to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code M32.1.

Impact

Clinical: Leads to misdiagnosis and inappropriate treatment., Regulatory: Increases audit risk due to lack of specificity., Financial: Potentially lowers reimbursement rates.

Mitigation Strategy

Educate providers on specific coding criteria, Implement regular chart audits

Impact

Reimbursement: May lead to lower reimbursement rates., Compliance: Increases risk of audit failures., Data Quality: Reduces accuracy of clinical data.

Mitigation Strategy

Query for specific features or antibodies to use more specific codes.

Impact

Failure to use specific codes when documentation supports them.

Mitigation Strategy

Conduct regular training sessions on documentation and coding specificity.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Connective Tissue Disease, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Connective Tissue Disease

Use these documentation templates to ensure complete and accurate documentation for Connective Tissue Disease. These templates include all required elements for proper coding and billing.

Rheumatology Progress Note

Specialty: Rheumatology

Required Elements

  • Subjective symptoms
  • Objective findings
  • Assessment
  • Plan

Example Documentation

**Subjective**: 52yo F with 6-month history of morning stiffness, photosensitive rash, dysphagia. **Objective**: Positive ANA 1:640, Anti-U1 RNP 1:1280. **Assessment**: M35.1 (Mixed CTD) with esophageal dysmotility. **Plan**: HRCT chest for ILD screening.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Patient has joint pain and fatigue.
Good Documentation Example
Positive ANA with speckled pattern, anti-U1 RNP >1:1000, Raynaud's phenomenon, and synovitis.
Explanation
The good example provides specific antibody results and clinical features, supporting a precise diagnosis.

Need help with ICD-10 coding for Connective Tissue Disease? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more

Helpful Links

How ICD 10 AI Lookup WorksContact UsPrivacy Policy